Recent Press Releases

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals LAVAL, Quebec, Sept. 25, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX)...

European CHMP Adopts Positive Opinion for Gilead's Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults

European CHMP Adopts Positive Opinion for Gilead's Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults FOSTER CITY, Calif., Sep 26, 2014 (BUSINESS WIRE)...

COMUNICADO: CHMP Recommends Approval of Lilly's Ramucirumab (CYRAMZA(TM)) for Advanced Gastric Cancer After Prior Chemotherapy (1)

COMUNICADO: CHMP Recommends Approval of Lilly's Ramucirumab (CYRAMZA(TM)) for Advanced Gastric Cancer After Prior Chemotherapy (1) Positive Opinion Is First Regulatory Action for Ramucirumab in...

Meeting highlights from the Committee for Medicinal Products for Human Use, 22-25 September 2014

Meeting highlights from the Committee for Medicinal Products for Human Use, 22-25 September 2014 Fifteen new medicines and three extensions of indication recommended for approval Fifteen new...

IRESSA RECEIVES CHMP POSITIVE OPINION TO INCLUDE BLOOD BASED DIAGNOSTIC TESTING IN EUROPEAN LABEL

IRESSA RECEIVES CHMP POSITIVE OPINION TO INCLUDE BLOOD BASED DIAGNOSTIC TESTING IN EUROPEAN LABEL 26 September 2014 AstraZeneca today announced that the Committee for Medicinal Products for Human Use...

MOVENTIG® (naloxegol) RECEIVES POSITIVE CHMP OPINION IN THE EU FOR THE TREATMENT OF ADULTS WITH OPIOID-INDUCED CONSTIPATION

MOVENTIG® (naloxegol) RECEIVES POSITIVE CHMP OPINION IN THE EU FOR THE TREATMENT OF ADULTS WITH OPIOID-INDUCED CONSTIPATION Friday, 26 September 2014 AstraZeneca today announced that the...

Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly

Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly Acromegaly is an endocrine disorder caused by elevated growth hormone (GH)...

Harvoni recommended for the treatment of chronic hepatitis C

Harvoni recommended for the treatment of chronic hepatitis C Growing number of treatment options improve patients' chances of longer and healthier lives The European Medicines Agency has recommended...

Actavis Confirms Generic Butrans® Patent Challenge

Actavis Confirms Generic Butrans® Patent Challenge DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with...

Almirall's aclidinium bromide/formoterol fumarate recommended for approval in Europe to treat COPD

Almirall's aclidinium bromide/formoterol fumarate recommended for approval in Europe to treat COPD Positive CHMP opinion is an important step in making this new respiratory therapy available to treat...

Indian industry decries smear campaign against its pharma exporters and Government also intrigued

Indian industry decries smear campaign against its pharma exporters and Government also intrigued New Delhi, September 26, 2014: The India Brand Equity Foundation (IBEF), on behalf of the Government...

Roche launches Global Access Program for HIV viral load testing

Roche launches Global Access Program for HIV viral load testing Program expands access to care supporting the Diagnostics Access Iniative PLEASANTON, Calif., Sept. 25, 2014 /PRNewswire/ -- Roche...

Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb

Editor Note: For more information about this release, please scroll to bottom.

LONDON, September 25, 2014

Roche launches Global Access Program for HIV viral load testing

Program expands access to care supporting the Diagnostics Access Initiative

PLEASANTON, Calif., Sept.

Universal Health Services, Inc. To Present At The Leerink Healthcare Services Roundtable

KING OF PRUSSIA, Pa., Sept. 25, 2014 /PRNewswire/ -- Universal Health Services, Inc.

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca

IGI Laboratories acquires regulatory rights for 18 drug products from AstraZeneca Published on September 25, 2014 IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic...

MannKind Announces Closing of Global Licensing Agreement With Sanofi

MannKind Announces Closing of Global Licensing Agreement With Sanofi VALENCIA, Calif., Sep 24, 2014 (GLOBE NEWSWIRE via COMTEX) -- MannKind Corporation MNKD, +0.49% today announced the closing of a...

Shire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices

Pharmaceutical company Shire Pharmaceuticals LLC will pay $56.5 million to resolve civil allegations that it violated the False Claims Act as a result of its marketing and promotion of several drugs,...

ESMO 2014 to Feature New Oncology Data from Across Bayer Franchise

WHIPPANY, N.J., Sept. 24, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.